Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lader

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Postgraduate Medical Journal|November 1, 1974
Interpretation of results obtained using digoxin radioimmunoassayS Lader, B Johnson
British Journal of Clinical Pharmacology|March 29, 2012
Bioavailability of digoxin from rapidly dissolving preparationsB F Johnson, S Lader
Endocrinology|June 30, 1998
Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitroC S Lader, A M Flanagan
Current Opinion in Hematology|July 17, 1998
Update on the biologic effects of macrophage colony-stimulating factorA M Flanagan, C S Lader
Postgraduate Medical Journal|November 1, 1974
The bioavailability of other digoxin preparations compared with tabletsB F Johnson, C Bye, S Lader
Developmental Biology|August 1, 1993
ZAP-1 DNA binding activity is first detected at the onset of zona pellucida gene expression in embryonic mouse oocytesS E Millar, E S Lader, J Dean
The American Journal of Physiology|December 22, 1999
Role of gelsolin in the actin filament regulation of cardiac L-type calcium channelsA S Lader, D J Kwiatkowski, H F Cantiello
Basic & Clinical Pharmacology & Toxicology|April 23, 2014
Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injurySteven A Kates, Alan S Lader, Ralph Casale, et al.
British Journal of Haematology|February 13, 2001
Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expressionC S Lader, J Scopes, M A Horton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1980
A pilot of plasma thioridazine and metabolites in chronically treated patientsA S Papadopoulos, T G Chand, J L Crammer, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Postgraduate Medical Journal|November 1, 1974
Interpretation of results obtained using digoxin radioimmunoassayS Lader, B Johnson
British Journal of Clinical Pharmacology|March 29, 2012
Bioavailability of digoxin from rapidly dissolving preparationsB F Johnson, S Lader
Endocrinology|June 30, 1998
Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitroC S Lader, A M Flanagan
Current Opinion in Hematology|July 17, 1998
Update on the biologic effects of macrophage colony-stimulating factorA M Flanagan, C S Lader
Postgraduate Medical Journal|November 1, 1974
The bioavailability of other digoxin preparations compared with tabletsB F Johnson, C Bye, S Lader
Developmental Biology|August 1, 1993
ZAP-1 DNA binding activity is first detected at the onset of zona pellucida gene expression in embryonic mouse oocytesS E Millar, E S Lader, J Dean
The American Journal of Physiology|December 22, 1999
Role of gelsolin in the actin filament regulation of cardiac L-type calcium channelsA S Lader, D J Kwiatkowski, H F Cantiello
Basic & Clinical Pharmacology & Toxicology|April 23, 2014
Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injurySteven A Kates, Alan S Lader, Ralph Casale, et al.
British Journal of Haematology|February 13, 2001
Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expressionC S Lader, J Scopes, M A Horton, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1980
A pilot of plasma thioridazine and metabolites in chronically treated patientsA S Papadopoulos, T G Chand, J L Crammer, et al.
Pageof 4